EME - 11/100/50

Molecular selection of therapy in metastatic colorectal cancer: a molecularly stratified randomised controlled trial programme (FOCUS 4)

Project title: Molecular selection of therapy in metastatic colorectal cancer: a molecularly stratified randomised controlled trial programme (FOCUS 4)

Call to action: 11/100 11/100 Initial Commissioning Brief - August 11 and January 12

Research type: Primary Research

Chief investigator: Professor Timothy Maughanorcid.org/0000-0002-0580-5065

Contractor: University of Oxford

Cost: £3,920,117.34

Co-investigators: Dr Angela Crook, Dr Gary Middleton, Dr Harpreet Wasan, Dr Rachel Butler, Dr Susan Richman, Professor Bharat Jasani, Professor Mahesh Parmar, Professor Philip Quirke, Professor Richard Adams, Professor Richard Kaplan, Professor Richard Wilson, Professor William Steward.

Started: April 2013 | Status: Research in progress

ISRCTN: 90061546

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.